BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1960717)

  • 1. Expression of the protease inhibitor ecotin and its co-crystallization with trypsin.
    McGrath ME; Erpel T; Browner MF; Fletterick RJ
    J Mol Biol; 1991 Nov; 222(2):139-42. PubMed ID: 1960717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystallization and preliminary X-ray crystallographic analysis of the protease inhibitor ecotin in complex with chymotrypsin.
    Lee CS; Seong IS; Song HK; Chung CH; Suh SW
    Acta Crystallogr D Biol Crystallogr; 1999 May; 55(Pt 5):1091-2. PubMed ID: 10216315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystallization and preliminary X-ray crystallographic analysis of the protease inhibitor ecotin.
    Shin DH; Hwang KY; Kim KK; Lee HR; Lee CS; Chung CH; Suh SW
    J Mol Biol; 1993 Feb; 229(4):1157-8. PubMed ID: 8445642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compromise and accommodation in ecotin, a dimeric macromolecular inhibitor of serine proteases.
    Gillmor SA; Takeuchi T; Yang SQ; Craik CS; Fletterick RJ
    J Mol Biol; 2000 Jun; 299(4):993-1003. PubMed ID: 10843853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sequence and reactive site of ecotin. A general inhibitor of pancreatic serine proteases from Escherichia coli.
    McGrath ME; Hines WM; Sakanari JA; Fletterick RJ; Craik CS
    J Biol Chem; 1991 Apr; 266(10):6620-5. PubMed ID: 2007606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ecotin: a serine protease inhibitor with two distinct and interacting binding sites.
    Yang SQ; Wang CI; Gillmor SA; Fletterick RJ; Craik CS
    J Mol Biol; 1998 Jun; 279(4):945-57. PubMed ID: 9642073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering bidentate macromolecular inhibitors for trypsin and urokinase-type plasminogen activator.
    Yang SQ; Craik CS
    J Mol Biol; 1998 Jun; 279(4):1001-11. PubMed ID: 9642077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macromolecular chelation as an improved mechanism of protease inhibition: structure of the ecotin-trypsin complex.
    McGrath ME; Erpel T; Bystroff C; Fletterick RJ
    EMBO J; 1994 Apr; 13(7):1502-7. PubMed ID: 8156987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable monomeric form of an originally dimeric serine proteinase inhibitor, ecotin, was constructed via site directed mutagenesis.
    Pál G; Szilágyi L; Gráf L
    FEBS Lett; 1996 May; 385(3):165-70. PubMed ID: 8647243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of ecotin dimerization in protease inhibition.
    Eggers CT; Wang SX; Fletterick RJ; Craik CS
    J Mol Biol; 2001 May; 308(5):975-91. PubMed ID: 11352586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ecotin: lessons on survival in a protease-filled world.
    McGrath ME; Gillmor SA; Fletterick RJ
    Protein Sci; 1995 Feb; 4(2):141-8. PubMed ID: 7757004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure analyses of uncomplexed ecotin in two crystal forms: implications for its function and stability.
    Shin DH; Song HK; Seong IS; Lee CS; Chung CH; Suh SW
    Protein Sci; 1996 Nov; 5(11):2236-47. PubMed ID: 8931142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The periplasmic serine protease inhibitor ecotin protects bacteria against neutrophil elastase.
    Eggers CT; Murray IA; Delmar VA; Day AG; Craik CS
    Biochem J; 2004 Apr; 379(Pt 1):107-18. PubMed ID: 14705961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The P1 reactive site methionine residue of ecotin is not crucial for its specificity on target proteases. A potent inhibitor of pancreatic serine proteases from Escherichia coli.
    Seong IS; Lee HR; Seol JH; Park SK; Lee CS; Suh SW; Hong YM; Kang MS; Ha DB; Chung CH
    J Biol Chem; 1994 Aug; 269(34):21915-8. PubMed ID: 8063835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining protein-protein interactions by oxidative cross-linking of a glycine-glycine-histidine fusion protein.
    Brown KC; Yu Z; Burlingame AL; Craik CS
    Biochemistry; 1998 Mar; 37(13):4397-406. PubMed ID: 9521759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification from Escherichia coli of a periplasmic protein that is a potent inhibitor of pancreatic proteases.
    Chung CH; Ives HE; Almeda S; Goldberg AL
    J Biol Chem; 1983 Sep; 258(18):11032-8. PubMed ID: 6411724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ecotin is a potent anticoagulant and reversible tight-binding inhibitor of factor Xa.
    Seymour JL; Lindquist RN; Dennis MS; Moffat B; Yansura D; Reilly D; Wessinger ME; Lazarus RA
    Biochemistry; 1994 Apr; 33(13):3949-58. PubMed ID: 8142399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystallization and preliminary crystallographic study of a component of the Escherichia coli tol system: TolB.
    Abergel C; Rigal A; Chenivesse S; Lazdunski C; Claverie JM; Bouveret E; Bénédetti H
    Acta Crystallogr D Biol Crystallogr; 1998 Jan; 54(Pt 1):102-4. PubMed ID: 9761825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity purification of recombinant trypsinogen using immobilized ecotin.
    Lengyel Z; Pál G; Sahin-Tóth M
    Protein Expr Purif; 1998 Mar; 12(2):291-4. PubMed ID: 9518472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ecotin is a potent inhibitor of the contact system proteases factor XIIa and plasma kallikrein.
    Ulmer JS; Lindquist RN; Dennis MS; Lazarus RA
    FEBS Lett; 1995 May; 365(2-3):159-63. PubMed ID: 7781771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.